Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evolocumab for Lipid Management in Renal Transplant Recipients
NCT04608474Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Feb 2021
- Primary completion
- Jan 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of evolocumab in hyperlipidemia, sponsored by Brigham and Women's Hospital. Started Feb 2021; status: completed.
02
Drugs
evolocumab
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT04608474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04608474.